Back to top
more

Fidelity Select Portfolios Biotechnology Portfolio: (MF: FBIOX)

(NASDAQ Mutual Funds) As of Aug 10, 2020 08:00 PM ET

 Add to portfolio

$23.26 USD

-0.20 (-0.85%)

Zacks MF Rank 1-Strong Buy of 5 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jun 30, 2020

Total Return %* Percentile Rank Objective
YTD 13.99 5
3 months 33.65 5
6 months 13.99 5
1 Year 30.72 1
3 Year 13.41 24
5 Year 4.08 70
10 Year 20.91 2

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 32.74
% Yield 0.32
% SEC Yield NA
Net Assets (Mil $) 6/30/2020 7,701.33
%Turnover 6/30/2020 50.00

Risk

3 Year 5 Year 10 Year
Beta 1.14 1.34 1.17
Alpha 2.56 -6.53 5.98
R Squared 0.62 0.50 0.41
Std. Dev. 24.46 28.00 24.60
Sharpe 0.61 0.26 3.00

Sector / Country Weightings

As of 6/30/2020 % of Portfolio
Health 63.19
Other 24.26
Services 11.31
Non-Durable 0.60
Industrial Cyclical 0.26
Technology 0.21
Finance 0.17

Portfolio Holdings

Top Equity Holdings
(As of 2/29/2020)
% of Portfolio Value (Mil$)
ABBVIE INC 11.31 748.96
NA 10.14 672.04
VERTEX PHARMACEUTICALS IN 4.54 300.80
NA 4.31 285.64
REGENERON PHARMACEUTICALS 3.27 216.55
SEATTLE GENETICS INC 2.48 164.41
ALNYLAM PHARMACEUTICALS I 2.25 149.36
ACCELERON PHARMA INC 2.21 146.36
SAREPTA THERAPEUTICS INC 1.66 109.69

Stock Holding % of Net Assets

As Of 2/29/2020
Total Issues 243
Avg. P/E 17.86
Avg. P/Book 4.96
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 28,346

Allocation

% of Portfolio
Large Growth 39.91
Large Value 0.00
Small Growth 11.67
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 34.10
High Yield Bond 0.00